Central glucocorticoid receptor: A new role in the cellular mechanisms of neuropathic pain

Reviews in the Neurosciences

Volumn 16, Issue 3, 2005, Pages 233-238

  Mao, Jianren ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Glucocorticoid receptor; Interleukin; Mitogen activated protein kinase; Nerve injury; Neuropathic pain; NMDA receptor; Protein kinase C

Indexed keywords

GLUCOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

HUMAN; INFLAMMATION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHIC PAIN; NOCICEPTION; PATHOGENESIS; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVIEW; SPINAL CORD DORSAL HORN;

EID: 27844471676     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2005.16.3.233     Document Type: Review

References (73)

1. Abraham I, Harkany T, Horvath K, Veenema AH, Penke B, Nyakas C, Luiten PG. Chronic corticosterone administration dose-dependently modulates Abeta(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis. J Neuroendocrinol 2000; 12: 486-494.
2. Arruda JL, Colburn RW, Rickman AJ, Rutkoski MD, DeLeo JA. Increase of intereleukin-6 mRNA in the spinal cord following peripheral injury in the rat: potential role of IL-6 in neuropathic pain. Brain Res Mol Brain Res 1998; 62: 228-235.
3. Arruda JL, Sweitzer S, Rutkowski MD, DeLeo JA. Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain. Brain Res 2000; 879: 216-225.
4. Barkhudaryan N, Dunn AJ. Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo- pituitary-adrenocortical axis. Neurochem Res 1999; 24: 1169-1180.
5. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436-441.
6. Borski RJ, Hyde GN, Fruchtman S. Signal transduction mechanisms mediating rapid, nongenomic effects of cortisol on prolactin release. Steroids 2002; 67: 539-548.
7. Budziszewska B, Jaworska L, Lason W. Repeated morphine administration down-regulates glucocorticoid, but not mineralocorticoid, receptors in the rat hippocampus. Psychoneuroendocrinology 1995; 20: 75-81.
8. Cameron SA, Dutia MB. Lesion-induced plasticity in rat vestibular nucleus neurons is dependent on glucocorticoid receptor activation. J Physiol 1999; 518: 151-158.
9. Cho K, Little HJ. Effects of corticosterone on excitatory amino acid responses in dopamine-sensitive neurons in the ventral tegmental area. Neuroscience 1999; 88: 837-845.
10. Cintra A, Fuxe K, Solfrini V, Agnati LF, Tinner B, Wilkstrom AC, Staino W, Okret S, Gustafsson J. Central peptidergic neurons as targets for glucocorticoid action. Evidence for the presence of glucocorticoid receptor immunoreactivity in various types of classes of peptidergic neurons. J Steroid Biochem Mol Biol 1991; 40: 93-103.
11. Cintra A, Molander C, Fuxe K. Colocalization of Fos- and glucocorticoid receptor-immunoreactivities is present only in a very restricted population of dorsal horn neurons of the rat spinal cord after nociceptive stimulation. Brain Res 1993; 632: 334-338.
12. Cintra A, Bhatnagar M, Chadi G, Tinner B, Lindberg J, Gustafsson J, Agnati LF, Fuxe K. Glial and neuronal glucocorticoid receptor immunoreactive cell populations in developing, adult, and aging brain. Ann NY Acad Sci 1994; 746: 42-61.
13. Compagnone NA, Mellon SH. Neurosteroids: biosynthesis and functions of these novel neuromodulators. Front Neuroendocrinol 2000; 21: 1-56.
14. Coussens CM, Kerr DS, Abraham WC. Glucocorticoid receptor activation lowers the threshold for NMDA-receptor-dependent homosynaptic long-term depression in the hippocampus through activation of voltage-dependent calcium channels. J Neurophysiol 1997; 78: 1-9.
15. De Bosscher K, Vanden Berghe W, Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr Rev 2003; 24: 488-522.
16. DeLeo JA, Colburn RW, Nichols M, Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J Interferon Cytokine Res 1996; 16: 695-700.
17. De Nicola AF, Moses DF, Gonzalez S, Orti E. Adrenocorticoid action in the spinal cord: some unique molecular properties of glucocorticoid receptors. Cell Mol Neurobiol 1989; 9: 179-192.
18. Devor M. Nerve pathophysiology and mechanisms of pain in causalgia. J Auto Nerv Sys 1983; 7: 371-384.
19. Diem R, Hobom M, Maier K, Weissert R, Storch MK, Meyer R, Bahr M. Methylprednisolone increases neuronal apoptosis during autoimmune CNS inflammation by inhibition of an endogenous neuroprotective pathway. J Neurosci 2003; 23: 6993-7000.
20. Drouin J, Sun YL, Tremblay S, Lavender P, Schmidt TJ, de Lean A, Nemer M. Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor. Mol Endocrinol 1992; 6: 1299-1309.
21. th World Congress on Pain. Pain Research and Clinical Management. Vol. 5. Amsterdam: Elsevier, 1991; 263-267.
22. Fuxe K, Diaz R, Cintra A, Bhatnagar M, Tinner B, Gustafsson JA, Ogren SO, Agnati LF. On the role of glucocorticoid receptors in brain plasticity. Cell Mol Neurobiol 1996; 16: 239-258.
23. Gonzalez S, Coirini H, Gonzalez Deniselle MC, Gonzalez S, Calandra R, De Nicola AF. Time-dependent effects of dexamethasone on glutamate binding, ornithine decarboxylase activity and polyamine levels in the transected spinal cord. J Steroid Biochem Mol Biol 1995; 55: 85-92.
24. Gracely RH, Lynch SA, Bennett GJ. Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain 1992; 51: 175-194.
25. Karst H, Nair S, Velzing E, Rumpff-van Essen L, Slagter E, Shinnick-Gallagher P, Joels M. Glucocorticoids alter calcium conductances and calcium channel subunit expression in basolateral amygdale neurons. Eur J Neurosci 2002; 16: 1083-1089.
26. Kingery WS, Castellote JM, Maze M. Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds. Pain 1999; 80: 555-566.
27. Kingery WS, Guo T, Agashe GS, Davies MF, Clark DJ, Maze M. Glucocorticoid inhibition of neuropathic limb edema and cutaneous neurogenic extravasation. Brain Res 2001; 913: 140-148.
28. Laughlin TM, Bethea JR, Yezierski RP, Wilcox GL. Cytokine involvement in dynorphin-induced allodynia. Pain 2000; 84: 159-167.
29. Lim G, Wang S, Zeng Q, Sung B, Mao J. Evidence for a long-term influence of chronic morphine on morphine tolerance: role of central glucocorticoid receptors. Pain 2005; 114: 81-92.
30. Lim G, Wang S, Zeng Q, Sung B, Mao J. Central glucocorticoid receptors contribute to the mechanisms of morphine tolerance. Anesthesiology 2005; 102: 832-837.
31. Limbourg FP, Liao JK. Nontranscriptional actions of the glucocorticoid receptors. J Mol Med 2003; 81: 168-174.
32. Lu J, Goula D, Sousa N, Almeida OF. Ionotropic and metabotropic glutamate receptor mediation of glucocorticoid-induced apoptosis in hippocampal cells and the neuroprotective role of synaptic N-methyl-D-aspartate receptors. Neuroscience 2003; 121: 123-131.
33. Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician 2002; 5: 182-199.
34. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ. Intrathecal GM1 ganglioside and local nerve anesthesia reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992; 584: 28-35.
35. Mao J, Price DD, Mayer DJ, Lu J, Hayes RL. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res 1992; 576: 254-262.
36. Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions. Pain 1995; 62: 259-274.
37. Mao J, Price DD, Mayer DJ. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain 1995; 61: 353-364.
38. Mao J, Price DD, Zhu J, Lu J, Mayer DJ. The inhibition of nitric oxide-activated poly(ADP-ribose) synthetase attenuates transsynaptic alteration of spinal cord dorsal horn neurons and neuropathic pain in the rat. Pain 1997; 72: 355-366.
39. McCullers DL, Sullivan PG, Scheff SW, Herman JP. Traumatic brain injury regulates adrenocorticosteroid receptor mRNA levels in rat hippocampus. Brain Res 2002; 947: 41-49.
40. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier S, Watkins LR. Spinal glia and proinflammatory cytokine mediate mirror-image neuropathic pain in rats. J Neurosci 2003; 23: 1026-1040.
41. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 2002; 22: 6724-6731.
42. Murphy PG, Ramer MS, Borthwick L, Gauldie J, Richardson PM, Bisby MA. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 1999; 11: 2243-2253.
43. Nair SM, Werkman TR, Craig J, Finnell R, Joels M, Eberwine JH. Corticosterone regulation of ion channel conductances and mRNA levels in individual hippocampal CA1 neurons. J Neurosci 1998; 18: 2685-2696.
44. Neal DR Jr, VanderBeek BL, Vazuez DM, Watson SJ Jr. Dexamethasone exposure during the neonatal period alters ORL-1 mRNA expression in the hypothalamic paraventricular nucleus and hippocampus of the adult rats. Brain Res Dev Brain Res 2003; 146: 15-24.
45. Neeck G, Renkawitz R, Eggert M. Molecular aspects of glucocorticoid hormone action in rheumatoid arthritis. Cytokines Cell Mol Ther 2002; 7: 61-69.
46. Oitzl MS, Fluttert M, Sutanto W, de Kloet ER. Continuous blockade of brain glucocorticoid receptors facilitates spatial learning and memory in rats. Eur J Neurosci 1998; 10: 3759-3766.
47. Okamoto K, Martin DP, Schmelzer JD, Mitsui Y, Low PA. Pro- and anti-inflammatory cytokines gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp Neurol 2001; 169: 386-391.
48. Opree A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 2000; 20: 6289-6293.
49. Plassart-Schiess E, Baulieu E. Neurosteroids: recent findings. Brain Res Brain Res Rev 2001; 37: 133-140.
50. Qiu J, Wang CG, Haung XY, Chen YZ. Nongenomic mechanism of glucocorticoid inhibition of bradykinin-induced calcium influx in PC12 cells: possible involvement of protein kinase C. Life Sci 2003; 72: 2533-2542.
51. Quirarte GL, Roozendaal B, McGaugh JL. Glucocorticoid enhancement of memory storage involves noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 1997; 94: 14048-14053.
52. Raghavendra V, Rutkowski MD, Deleo JA. The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats. J Neurosci 2002; 22: 9980-9989.
53. Reeve AJ, Patel S, Fox A, Walker K, Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 2000; 4: 247-257.
54. Refojo D, Liberman AC, Holsboer F, Arzt E. Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids. Immunol Cell Biol 2001; 79: 385-394.
55. Roosendaal B, Williams GL, McGaugh JL. Glucocorticoid receptor activation in the rat nucleus of the solitary tract facilitates memory consolidation: involvement of the basolateral amygdala. Eur J Neurosci 1999; 11: 1317-1323.
56. Roosendaal B, Mcreynolds JJ, McGaugh JL. The basolateral amygdala interacts with the medial prefrontal cortex in regulating glucocorticoid effects on working memory impairment. J Neurosci 2004; 24: 1385-1392.
57. Schafers M, Svensson CI, Sommer C, Sorkin LS. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003; 23: 2517-2521.
58. Sommer C, Petrausch S, Lindenlaub T, Toyka KV. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999; 270: 25-28.
59. Song C, Phillips AG, Leonard B. Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. Eur J Neurosci 2003; 18: 1739-1743.
60. Sorkin LS, Doom CM. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J Peripher Nerv Syst 2000; 5: 96-100.
61. Sugimoto T, Bennett GJ, Kajander KC. Trans-synaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of a chronic constriction injury, transaction, and strychnine. Pain 1990; 42: 205-213.
62. Sweitzer S, Martin D, DeLeo JA. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an antiallodynic action in a rat model of neuropathic pain. Neuroscience 2001; 103: 529-539.
63. 2+ elevation in cultured rat hippocampal neurons. J Neurochem 2002; 83: 1441-1451.
64. Thomas PK. Clinical features and differential diagnosis of peripheral neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral Neuropathy. Philadelphia, PA: W.B. Saunders Co., 1984; 1169-1190.
65. Twining CN, Sloane CM, Milligan ED, Chacur M, Martin D, Poole S, Marsh H, Maier SF, Watkins LR. Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats. Pain 2004; 110: 299-309.
66. Vallee M, Mayo W, Koob GF, Le Moal M. Neurosteroids in learning and memory. Int Rev Neurobiol 2001; 46: 273-320.
67. Vardimon L, Ben-Dror I, Avisar N, Oren A, Shiftan L. Glucocorticoid control of glial gene expression. J Neurobiol 1999; 40: 513-527.
68. Wang S, Lim G, Zeng Q, Sung B, Ai Y, Guo G, Yang L, Mao J. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviors in rats. J Neurosci 2004; 24: 8595-8605.
69. Wang S, Lim G, Zeng Q, Yang L, Sung B, Mao J. Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 2005; 25: 488-495.
70. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997; 71: 225-235.
71. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 2001; 24: 450-455.
72. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959-1964.
73. Yan P, Xu J, Li Q, Chen S, Kim GM, Hsu CY, Xu XM. Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats. J Neurosci 1999; 19: 9355-9363.